Status:
COMPLETED
Insulin Glulisine in Healthy Lean and Obese Subjects
Lead Sponsor:
Sanofi
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
Primary objective * To investigate pharmacodynamic and pharmacokinetic parameters after s.c. administration of two different doses (low dose, 0.2 IU/kg and high dose, 0.4 IU/kg) of insulin glulisine ...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- Normal HbA1c
- Women have to either be postmenopausal, surgically sterilized, or not pregnant and using adequate contraception.
- Exclusion criteria :
- Systemic concomitant medication
Exclusion
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00311077
Start Date
April 1 2004
Last Update
December 7 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.